Prolonged effect of allergen sublingual immunotherapy to grass pollen

References

• Bousquet J, Khaltaev N, Crus AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, et al. Allergic rhinitis and its impact on asthma (ARIA)2008. Allergy. 2008;63:8–160.
   PubMed Web of Science ®Google Scholar
• Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378:2112–2122. doi:10.1016/S0140-6736(11)60130-X.
   PubMed Web of Science ®Google Scholar
• Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, Cox L, Demoly P, Frew AJ, O’Hehir R, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2016;137:358–568. doi:10.1016/j.jaci.2015.12.1300.
   PubMed Web of Science ®Google Scholar
• Agache I, Angier L, Bonertz A, Dhami S, Rivas M, van Wijk RG, Halken S, Jutel M, Lau S, Pajno G, et al. Allergen immunotherapy guidelines. Part 2: recommendations. Eur Acad Clin Immunol (EAACI). 2017;1:1–167.
   Google Scholar
• Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, Agarwal A, Netuveli G, Roberts G, Pfaar O. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017; doi:10.1111/all.13201.
   Google Scholar
• Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a ranodmized, controlled trial. J Allergy Clin Immunol. 2001;107:87–93. doi:10.1067/mai.2001.112027.
   PubMed Web of Science ®Google Scholar
• Klimek L, Uhlig J, Mosges R, Rettig K, Pfaar O. A high polymerized grass pollen extract is effcacious and safe in a randomized double-blind, placebo controlled study using a novel up-dosing cluster protocol. Allergy. 2014;69:1629–1638. doi:10.1111/all.12513.
   PubMed Web of Science ®Google Scholar
• Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;118:434–440. doi:10.1016/j.jaci.2006.05.003.
   PubMed Web of Science ®Google Scholar
• Asero R. Efficacy of injection immunotherapy with ragweed and birch pollen in elderly patients. Int Arch Allergy Immunol. 2004;135:332–335. doi:10.1159/000082328.
   PubMed Web of Science ®Google Scholar
• Bozek A, Kolodziejczyk K, Krajewska-Wojtys A, Jarzab J. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass. Ann Allergy Asthma Immunol. 2016;116(2):156–161. doi:10.1016/j.anai.2015.12.013.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ, Passalacqua G, Potter P, Valovirta E. Recommendations for standardizationof clinical trials withAllergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy. 2007;62:317–324. doi:10.1111/j.1398-9995.2007.01456.x.
   PubMed Web of Science ®Google Scholar
• Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy. 2002;57(4):306–312.
   PubMed Web of Science ®Google Scholar
• Didier A, Hj M, Worm M, Horak F, Sussman Gl. Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score. Clin Transl Allergy. 2015;22(5):12. doi:10.1186/s13601-015-0057-8.
   Google Scholar
• Dominicus S. 3-years’ long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adults. Eur Ann Allergy Clin Immunol. 2012;44(3):135–140.
   PubMedGoogle Scholar
• Bożek A, Kołodziejczyk K, Kozłowska R, Canonica GW. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial. Clin Transl Allergy. 2017;1(7):43. doi:10.1186/s13601-017-0180-9.
   Google Scholar
• Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le GM, Melac M, Hj M. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol. 2011;128(3):559–566. doi:10.1016/j.jaci.2011.06.022.
   PubMed Web of Science ®Google Scholar
• Yilmaz Sahin AA, Corey JP. Rhinitis in the elderly. Curr Allergy Asthma Rep. 2006;6:125–131.
   PubMed Web of Science ®Google Scholar
• Klimek L, Schendzielorz P, Pinol R, Pfaar O. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study. Clin Exp Allergy. 2012;42(6):936–945. doi:10.1111/j.1365-2222.2012.03971.x.
   PubMed Web of Science ®Google Scholar
• Grouin JM, Vicaut E, Jean-Alphonse S, Demoly P, Wahn U, Didier A, de Beaumont O, Montagut A, Le Gall M, Devillier P. The average adjusted symptom score, a new primary efficacy end-point for specific allergen immunotherapy trials. Clin Exp Allergy. 2011;41:1282–1288. doi:10.1111/j.1365-2222.2011.03700.x.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Patterson R. Impact of allergic rhinitis treatment on quality of life. Pharmacoeconomics. 2001;19:891–899.
   PubMed Web of Science ®Google Scholar
• Heinzerling LM, Burbach GJ, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet PJ, Bresciani M. GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy. 2009;64:1498–1506. doi:10.1111/j.1398-9995.2009.02093.x.
   PubMed Web of Science ®Google Scholar